These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 605413)

  • 1. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D; Zonew I; Milanow S
    Ther Hung; 1977; 25(4):145-9. PubMed ID: 605413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F; Melluso K; Campisi R; Carducci Artenisio A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C; Höffken B; Morgner KD
    Verh Dtsch Ges Inn Med; 1974; 80():1328-30. PubMed ID: 4454413
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly].
    Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B
    Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levodopa and somatotropic hormone in diabetes].
    Carducci Artenisio A; Ragonese F; Martelli G; Forte F; Campisi R; Consolo F
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1972-7. PubMed ID: 753286
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F; Massara F; Molinatti GM
    Biomedicine; 1974 Jun; 21(6):241-3. PubMed ID: 4441586
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses.
    Kuska J; Kokot F; Sledziński Z
    Acta Med Pol; 1979; 20(3):217-26. PubMed ID: 517160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A; Ragonese F; Albanese MC; Alibrando S; Allegra V
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):946-52. PubMed ID: 4463984
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E; Souvatzoglou A; von Werder K
    Verh Dtsch Ges Inn Med; 1974; 80():1325-8. PubMed ID: 4454412
    [No Abstract]   [Full Text] [Related]  

  • 10. Study on growth hormone and prolactin secretions in myotonic dystrophy.
    Canal N; Smirne S; Comi G; Guidobono F; Pecile A; Caviezel F
    Acta Neurol Belg; 1982; 82(3):178-84. PubMed ID: 7051737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A; De Marinis L; Martino F
    J Endocrinol Invest; 1978 Jul; 1(3):259-61. PubMed ID: 756876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa stimulation of glucagon secretion in man.
    Rayfield EJ; George DT; Eichner HL; Hsu TH
    N Engl J Med; 1975 Sep; 293(12):589-91. PubMed ID: 1152893
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO; Stoa RF; Thorsen T; Aarskog D
    Acta Paediatr Scand; 1977 Jan; 66(1):81-4. PubMed ID: 831384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
    Babakhanov KhB
    Lab Delo; 1975; (10):605-7. PubMed ID: 54462
    [No Abstract]   [Full Text] [Related]  

  • 17. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T; Welnic J; Woitalla D; Muhlack S
    Neurosci Lett; 2007 Jul; 422(2):119-22. PubMed ID: 17590511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
    Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion].
    Rolandi E; Barreca T; Masturzo P; Polleri A
    Boll Soc Ital Biol Sper; 1975 Jun; 51(12):751-4. PubMed ID: 1222097
    [No Abstract]   [Full Text] [Related]  

  • 20. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.